Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman, Christoph Wanner, John Lachin, D Fitchett, Erich Bluhmki, Stefan Hantel, M Mattheus, Theresa Devins, Odd Johansen, H J Woerle, Joseph Selvanayagam

Research output: Contribution to journalArticlepeer-review

5596 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences